Inhibition of neutrophil infiltration into A549 lung tumors in vitro and in vivo using a CXCR2-specific antagonist is associated with reduced tumor growth

Plasticity in Tumor-Promoting Inflammation: Impairment of Macrophage Recruitment Evokes a Compensatory Neutrophil Response

(2015) Jessica C. Pahler et al.   NEOPLASIA

CXCR2 Promotes Ovarian Cancer Growth through Dysregulated Cell Cycle, Diminished Apoptosis, and Enhanced Angiogenesis

(2010) G. Yang et al.   CLINICAL CANCER RESEARCH

Neutrophils: key mediators of tumour angiogenesis

(2010) Simon Tazzyman et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

(2009) Zvi G. Fridlender et al.   CANCER CELL

Host CXCR2-Dependent Regulation of Melanoma Growth, Angiogenesis, and Experimental Lung Metastasis

(2009) S. Singh et al.   CANCER RESEARCH

Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis

(2009) S. Singh et al.   CLINICAL CANCER RESEARCH

CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer

(2009) Yoichi Matsuo et al.   INTERNATIONAL JOURNAL OF CANCER

Small interfering RNA-mediated CXCR1 or CXCR2 knock-down inhibits melanoma tumor growth and invasion

(2009) Seema Singh et al.   INTERNATIONAL JOURNAL OF CANCER

The Interleukin-8 Pathway in Cancer

(2008) D. J.J. Waugh et al.   CLINICAL CANCER RESEARCH

Combined IL-8 and TGF-β blockade efficiently prevents neutrophil infiltrates into an A549-cell tumor

(2008) Kristy Kazemfar et al.   IMMUNOLOGY LETTERS

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE

Evaluation of a series of bicyclic CXCR2 antagonists

(2007) Iain Walters et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS